Archive for 2017

Drug Patent Expirations for the Week of December 24, 2017

SPINRAZA (nusinersen sodium) Biogen idec Patent: 6,166,197 Expiration: Dec 26, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]ntWatch.com…
The…


New patent expiration for Kastle Theraps drug KYNAMRO

Annual Drug Patent Expirations for KYNAMRO Kynamro is a drug marketed by Kastle Theraps Llc and is included in one NDA. It is available from two suppliers. There are six…
The post New patent expiration for Kastle Theraps drug KYNAMRO appeared fir…


New patent expiration for Biogen Idec drug SPINRAZA

Annual Drug Patent Expirations for SPINRAZA Spinraza is a drug marketed by Biogen Idec and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Biogen Idec drug SPINRAZA appeared f…


New patent expiration for Novo Nordisk drug NORDITROPIN NORDIFLEX

Annual Drug Patent Expirations for NORDITROPIN+NORDIFLEX Norditropin Nordiflex is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Novo Nordisk drug …


New patent expiration for Novo Nordisk drug NORDITROPIN FLEXPRO

Annual Drug Patent Expirations for NORDITROPIN+FLEXPRO Norditropin Flexpro is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Novo Nordisk drug NORD…


Which pharmaceutical drugs have the most drug patents in Eurasian Patent Organization?

This chart shows the drugs with the most patents in Eurasian Patent Organization. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
The post Which pharmaceutical drugs have the most drug pat…


Do NOT follow this link or you will be banned from the site!